Stock Information
Ligand Pharmaceuticals Inc (LGND)
Ticker Symbol: LGND
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $4,821.57 mil
Piotroski score: 7
PE Ratio: 33.1715
EPS (TTM): 5.8832
Revenue (TTM): $12.97 M
Dividend Yield: N/A%
ROE: 13.86%
Latest News
-
Ligand Pharmaceuticals Incorporated 2026 Q1 - Results - Earnings Call Presentation
Fri, May 8, 2026 4:31 PM
-
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Fall on Q1 Revenue and EPS Miss
Thu, May 7, 2026 12:27 PM
-
Ligand Pharmaceuticals Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2026
Thu, May 7, 2026 11:42 AM
-
Ligand Pharmaceuticals Incorporated : First Quarter 2026 Earnings Webcast
Thu, May 7, 2026 7:49 AM
-
Ligand: Q1 Earnings Snapshot
Thu, May 7, 2026 7:29 AM
-
Ligand Pharmaceuticals Affirms FY2026 Adj EPS Guidance of $8.50-$9.50 vs $9.13 Est; Affirms FY2026 Sales Guidance of $270.000M-$310.000M vs $281.535M Est
Thu, May 7, 2026 7:05 AM
-
Ligand Pharmaceuticals Q1 Adj. EPS $1.63 Misses $1.82 Estimate, Sales $51.722M Miss $58.696M Estimate
Thu, May 7, 2026 7:04 AM
-
Ligand Reports First Quarter 2026 Financial Results
Thu, May 7, 2026 7:03 AM
-
Orchestra BioMed Receives $15M Payment From Ligand Pharma Under Previously Disclosed Revenue Participation Right Purchase And Sale Agreement
Wed, May 6, 2026 8:07 AM
-
Ligand to Participate in May Investor Conferences
Tue, May 5, 2026 4:02 PM
Key Financials
Financial data not available
